EXPERT
Dr. Nausherwan K. Burki, MD
Pulmonologist
Dr. Nausherwan K Burki MD is a top Pulmonologist in Farmington, . With a passion for the field and an unwavering commitment to their specialty, Dr. Nausherwan K Burki MD is an expert in changing the lives of their patients for the better. Through their designated cause and expertise in the field, Dr. Nausherwan K Burki MD is a prime example of a true leader in healthcare. As a leader and expert in their field, Dr. Nausherwan K Burki MD is passionate about enhancing patient quality of life. They embody the values of communication, safety, and trust when dealing directly with patients. In Farmington, CT, Dr. Nausherwan K Burki MD is a true asset to their field and dedicated to the profession of medicine.
62 years
Experience
Dr. Nausherwan K. Burki, MD
- Farmington, CT
- King Edward Medical University
- Accepting new patients
No results found
Can TB recur in a person?
With proper treatment of TB the chances of recurrence are less than 1%. So the likelihood of these symptoms being due to recurrent TB are very low, but the patient should see READ MORE
With proper treatment of TB the chances of recurrence are less than 1%. So the likelihood of these symptoms being due to recurrent TB are very low, but the patient should see a doctor for a full examination.
Can air purifiers restrict my child's immunity?
There is no data relating air purifiers to immunity. However, there is data indicating that children who are kept away from all likely allergens in infancy and childhood are more READ MORE
There is no data relating air purifiers to immunity. However, there is data indicating that children who are kept away from all likely allergens in infancy and childhood are more prone to developing allergic diseases such as asthma.
I have to undergo chemotherapy for lung cancer. What should I expect?
I shall limit my answer to the effects of chemotherapy for lung cancer.
The choice of chemotherapy is based on the stage, cell type and molecular characteristics of the tumor. READ MORE
I shall limit my answer to the effects of chemotherapy for lung cancer.
The choice of chemotherapy is based on the stage, cell type and molecular characteristics of the tumor. Depending on the molecular features of the tumor, i.e., presence of driver mutations or a high concentration of cells expressing programmed death ligand I mutations (PD-L1), therapy may consist of immunotherapy or in the absence of these or with low concentrations of PD-L1, or where the mutation status is unknown, treatment is with chemotherapy.
Commonly used chemotherapy drugs for lung cancer are cisplatin plus gemcitabine, pemetrexed, and erlotinib. The monoclonal antibodies, bevacizumab or pembrolizumab may be added to therapy.
With chemotherapy, you should expect some side effects. The severity of the side effects is dependent on how aggressively you are treated, i.e., the dose and frequency of the chemotherapy drugs.
You will probably notice some fatigue, and you may develop nausea, possibly vomiting (these can be ameliorated by anti-nausea medications); diarrhea may also occur. There may be skin rashes and loss of hair. You may develop some tingling and loss of sensation in the feet and hands, and there is a risk of some hearing loss. These drugs reduce the white blood cells in your blood as well some clotting factors and there is a possibility of kidney and liver injury. With cessation of therapy these side effects usually disappear. Your physician will adjust the dose depending on your age and other comorbidities, and should carefully monitor you for these side effects and adjust the dose accordingly.
N. Burki
The choice of chemotherapy is based on the stage, cell type and molecular characteristics of the tumor. Depending on the molecular features of the tumor, i.e., presence of driver mutations or a high concentration of cells expressing programmed death ligand I mutations (PD-L1), therapy may consist of immunotherapy or in the absence of these or with low concentrations of PD-L1, or where the mutation status is unknown, treatment is with chemotherapy.
Commonly used chemotherapy drugs for lung cancer are cisplatin plus gemcitabine, pemetrexed, and erlotinib. The monoclonal antibodies, bevacizumab or pembrolizumab may be added to therapy.
With chemotherapy, you should expect some side effects. The severity of the side effects is dependent on how aggressively you are treated, i.e., the dose and frequency of the chemotherapy drugs.
You will probably notice some fatigue, and you may develop nausea, possibly vomiting (these can be ameliorated by anti-nausea medications); diarrhea may also occur. There may be skin rashes and loss of hair. You may develop some tingling and loss of sensation in the feet and hands, and there is a risk of some hearing loss. These drugs reduce the white blood cells in your blood as well some clotting factors and there is a possibility of kidney and liver injury. With cessation of therapy these side effects usually disappear. Your physician will adjust the dose depending on your age and other comorbidities, and should carefully monitor you for these side effects and adjust the dose accordingly.
N. Burki
